1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- manufacturers
- ASN06917370
-
-
2026-05-11
- CAS:837404-68-9
- Purity:
- Supply Ability: 10g
|
| | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- Basic information |
| Product Name: | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- | | Synonyms: | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]-;ASN 06917370;ASN06917370;ASN-06917370 | | CAS: | 837404-68-9 | | MF: | C24H21ClF3N7O2 | | MW: | 531.92 | | EINECS: | | | Product Categories: | | | Mol File: | 837404-68-9.mol | ![1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- Structure](CAS/20210305/GIF/837404-68-9.gif) |
| | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- Chemical Properties |
| density | 1.56±0.1 g/cm3(Predicted) | | pka | 13.43±0.70(Predicted) | | form | Solid | | color | White to off-white |
| | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- Usage And Synthesis |
| Description | ASN06917370 is a GPR17 receptor modulator. ASN06917370 can be used for neuroprotective and/or reparatory purposes, in cerebral, cardiac and renal ischaemia, in cerebral trauma, in chronic neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), and in demyelinating diseases such as multiple sclerosis. | | Uses | ASN06917370 is a former orphan receptor GPR17 ligand for the study of neurodegenerative diseases. ASN06917370 has an EC50 of 268 pM in [35S]GTPyS experiments[1]. | | References | [1] Eberini I, et al. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. J Comput Aided Mol Des. 2011 Aug;25(8):743-52. DOI:10.1007/s10822-011-9455-8 |
| | 1-Piperidinecarboxamide, 4-[3-[(2-chlorophenyl)methyl]-6,7-dihydro-7-oxo-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl]-N-[4-(trifluoromethyl)phenyl]- Preparation Products And Raw materials |
|